S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How Biden has already won 2024 (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
He Is Giving Away Bitcoin (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
1970’s computer coder issues shocking A.I. warning (Ad)
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How Biden has already won 2024 (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
He Is Giving Away Bitcoin (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
1970’s computer coder issues shocking A.I. warning (Ad)
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How Biden has already won 2024 (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
He Is Giving Away Bitcoin (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
1970’s computer coder issues shocking A.I. warning (Ad)
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How Biden has already won 2024 (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
He Is Giving Away Bitcoin (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
1970’s computer coder issues shocking A.I. warning (Ad)
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
Free Trial
NYSE:ISR

Isoray (ISR) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free ISR Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
N/A
50-Day Range
$0.28
▼
$0.42
52-Week Range
N/A
Volume
145,000 shs
Average Volume
290,697 shs
Market Capitalization
$54.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
ISR stock logo

About Isoray Stock (NYSE:ISR)

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

ISR Stock News Headlines

November 22, 2023 | morningstar.com
French ISR Label Revamp Report
April 24, 2023 | thestreet.com
Why IsoRay (ISR) Is Plunging Today
April 19, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
March 16, 2023 | thestreet.com
Why IsoRay (ISR) Stock Is Surging Today
February 16, 2023 | finance.yahoo.com
IsoRay (ISR) Reports Q2 Loss, Misses Revenue Estimates
February 16, 2023 | finance.yahoo.com
Perspective Therapeutics (formerly known as Isoray, Inc.) Announces Financial Results for the Quarter ended December 31, 2022
February 8, 2023 | finanznachrichten.de
Isoray, Inc.: Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce Name Change to Perspective Therapeutics Inc.
February 7, 2023 | finance.yahoo.com
Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce Name Change to Perspective Therapeutics Inc.
April 19, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
February 6, 2023 | finance.yahoo.com
Isoray Completes Merger with Viewpoint Molecular Targeting to Advance New Treatment Paradigm in Targeted Precision Oncology Medicine
January 30, 2023 | benzinga.com
Isoray Announces Results of Fiscal 2023 Annual Meeting of Stockholders
January 30, 2023 | finance.yahoo.com
Isoray Announces Results of Fiscal 2023 Annual Meeting of Stockholders
January 14, 2023 | thestreet.com
Why IsoRay (ISR) Hit a Five-Year High Today (Update)
January 12, 2023 | finance.yahoo.com
Isoray Announces Adjournment of Annual Meeting of Stockholders to January 27, 2023
December 14, 2022 | finance.yahoo.com
Isoray Announces Adjournment of Annual Meeting of Stockholders to January 12, 2022
December 14, 2022 | finance.yahoo.com
AMENDED: Isoray Announces Adjournment of Annual Meeting of Stockholders to January 12, 2023
December 6, 2022 | proactiveinvestors.com
Isoray's merger with Viewpoint Molecular Targeting sets up big opportunity in 2023
December 6, 2022 | proactiveinvestors.com
Isoray releases Q1 financials as company looks ahead to merger with Viewpoint Molecular Targeting
November 25, 2022 | finance.yahoo.com
Isoray, Inc. (ISR) Stock Historical Prices & Data - Yahoo Finance
November 11, 2022 | finanznachrichten.de
Isoray, Inc.: Isoray Announces First Quarter Fiscal 2023 Financial Results and Provides Update to Pending Merger
November 10, 2022 | seekingalpha.com
Isoray, Inc. (ISR) Q1 2023 Earnings Call Transcript
November 10, 2022 | finance.yahoo.com
Isoray Announces First Quarter Fiscal 2023 Financial Results and Provides Update to Pending Merger
October 31, 2022 | finance.yahoo.com
Isoray To Announce First Quarter Fiscal 2023 Financial Results on November 10, 2022
October 20, 2022 | seekingalpha.com
Isoray Stock: Not Going Anywhere Anytime Soon (NYSE:ISR) - Seeking Alpha
October 18, 2022 | businesswire.com
Isoray Medical, Inc. and Viewpoint Molecular Targeting, Inc. Announce Investor Webcast on October 19, 2022 at 4:15 p.m. EDT - Business Wire
October 18, 2022 | finance.yahoo.com
Isoray Medical, Inc. and Viewpoint Molecular Targeting, Inc. Announce Investor Webcast on October 19, 2022 at 4:15 p.m. EDT
October 16, 2022 | benzinga.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SMBC, BTRS, ISR, JVA - Isoray (AMEX:ISR), BTRS H - Benzinga
See More Headlines
Receive ISR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Isoray and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/10/2021
Today
4/19/2024
Fiscal Year End
6/30/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NYSE:ISR
CUSIP
N/A
CIK
728387
Web
isoray.com
Phone
(509) 375-1202
Fax
509-267-3670
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-7,270,000.00
Net Margins
-115.91%
Pretax Margin
-91.45%
Return on Equity
-17.12%
Return on Assets
-16.15%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
14.38
Quick Ratio
13.99

Sales & Book Value

Annual Sales
$10.80 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.43 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
142,110,000
Free Float
138,674,000
Market Cap
$54.57 million
Optionable
Not Optionable
Beta
1.48
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover
10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Lori A. Woods
    Chief Executive Officer & Director
  • Jennifer Streeter
    Chief Operating Officer & VP-Human Resources
  • Mark J. Austin
    Co-CFO, Secretary & Chief Accounting Officer
  • Jonathan R. Hunt
    CFO & Principal Financial Officer
  • William A. Cavanagh
    Chief Research & Development Officer

Key Competitors

View All Competitors

ISR Stock Analysis - Frequently Asked Questions

How were Isoray's earnings last quarter?

Isoray, Inc. (NYSE:ISR) released its quarterly earnings results on Wednesday, November, 10th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.01) by $0.01. The company had revenue of $2.56 million for the quarter, compared to analyst estimates of $2.58 million. Isoray had a negative net margin of 115.91% and a negative trailing twelve-month return on equity of 17.12%.

This page (NYSE:ISR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Urgent alert: open this for a huge profit potential
Timothy Sykes
The #1 Crypto for 2024
InvestorPlace